Related Experiment Video
Updated: May 16, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Hypercoagulability in β-thalassemia: a status quo
Maria Domenica Cappellini1, Erika Poggiali, Ali T Taher
1Department of Internal Medicine, IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, University of Milan, Milan, Italy. maria.cappellini@unimi.it
Expert Review of Hematology
|November 14, 2012
Summary
Thalassemia patients face increased thrombosis risk due to a hypercoagulable state. This review explores the causes, characteristics, and prevention strategies for blood clots in thalassemia.
Area of Science:
- Hematology
- Vascular Medicine
- Genetics
Background:
- Improved life expectancy for thalassemia patients has revealed new chronic disease complications.
- Thrombosis is an increasingly recognized complication in individuals with thalassemia.
- Thalassemia intermedia patients exhibit a particularly high prevalence of thromboembolic events.
Purpose of the Study:
- To review the clinical and pathophysiological aspects of hypercoagulability in thalassemia.
- To discuss current knowledge regarding thrombosis in thalassemia patients.
- To explore strategies for preventing thrombotic events in this population.
Main Methods:
- Literature review of clinical studies and pathophysiological research.
- Analysis of data on hypercoagulability markers in thalassemia.
- Synthesis of information on thrombotic event prevalence and risk factors.
Main Results:
- Thalassemia is associated with a hypercoagulable state, increasing thrombosis risk.
- Specific clinical and pathophysiological factors contribute to hypercoagulability.
- Thrombotic events are a significant concern, particularly in thalassemia intermedia.
Conclusions:
- Hypercoagulability is a key factor in thrombosis development in thalassemia patients.
- Understanding these mechanisms is crucial for patient management.
- Preventive strategies are essential to mitigate thrombotic risks and improve outcomes.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:49Multiple Allele Traits
The Concept of Multiple Allelism
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...